On February 12, 2026, a Texas federal court vacated the FTC's expanded Hart-Scott-Rodino premerger notification rule but stayed its order for seven days, leaving the new form in place until at least February 19. Over the next decades, the balance of power between courts, agencies, and Congress will determine how intrusive merger filings become. The most likely outcome is a modestly scaled-back rule set, with enforcement agencies compensating through targeted second requests and post-closing challenges.
Verdict: Legal analyses agree that the Eastern District of Texas vacated the FTC's expanded HSR form after finding that asserted benefits did not reasonably outweigh substantial compliance costs (Covington, 2026-02-13; Debevoise, 2026-02-13). The order is stayed for seven days, during which parties must continue using the new form while the FTC considers emergency relief (Kirkland & Ellis, 2026-02-13; MLex, 2026-02-13). Most observers expect an appeal and potential remand, leaving room for narrower, better-justified disclosure requirements rather than a full return to the old regime (King & Spalding, 2026-02-13; Axinn, 2026-02-16).
The Fifth Circuit upholds the vacatur but clearly outlines how the FTC can justify a more focused set of additional disclosures. The agency responds with a slimmer, empirically grounded form that targets high-risk deals while easing burden on straightforward transactions. Over time, courts defer to this narrower rule, and merging parties gain a more predictable, risk-based filing regime.
Appeals produce a mixed outcome that preserves agency authority but pressures the FTC to scale back and better justify the most demanding elements of the new form. Companies face a moderately lighter filing burden but continued intensive reviews for complex or high-profile mergers. Enforcement agencies rely more on second requests, remedies, and post-closing challenges to police anticompetitive conduct.
Appellate decisions and parallel litigation significantly constrain the FTC's ability to expand premerger reporting, emboldening challenges to other procedural tools. A reversion toward the older, lighter HSR framework leaves agencies more dependent on limited staff and ex post enforcement. Some anticompetitive mergers slip through more easily, especially in fragmented or fast-moving digital and healthcare markets.
A major economic or political shock, such as a high-profile merger failure or sectoral crisis, triggers bipartisan support for new merger-control legislation. Congress rewrites elements of the HSR framework, possibly centralizing more power at the Department of Justice or creating specialized merger courts. The resulting system could be either more stringent or more permissive than today's, depending on the political coalition that prevails.
Developments: Through at least February 19, 2026, merging parties continue using the expanded HSR form while awaiting appellate signals and potential emergency relief. Law firms issue frequent client alerts explaining how to handle transactions that straddle any rule change dates, emphasizing conservative assumptions. The FTC and DOJ refine internal guidance on how to treat filings and whether to pause or proceed with certain investigative steps during legal uncertainty.
Risks: Confusion about which form applies on which date could lead to filing defects or delays, increasing closing risk for time-sensitive transactions. Some firms may gamble on minimal compliance in expectation that the new rule will fall, risking enforcement backlash if courts preserve key elements. Political actors might use the case to argue for broader curbs on agency power, spilling into unrelated areas of competition policy.
Outlook: Transactional practice centers on risk management under overlapping regimes. Most deals proceed with cautious over-compliance rather than exploiting uncertainty. Early appellate motions set the tone but not the final shape of merger review.
Developments: Appeals and follow-on litigation clarify how much the FTC can demand in premerger filings and how rigorously it must justify each requirement. The agency either reissues a trimmed-down version of the form or adopts guidance that informally narrows its expectations while preserving legal authority. Frequent filers adapt internal data collection processes so that producing competition-relevant information becomes more routine and less ad hoc.
Risks: If judicial standards are vague, agencies and firms may interpret them differently, leading to disputes, supplemental filings, and delays. A perception that courts are hostile to enforcement could nudge agencies toward focusing primarily on the clearest cases, leaving more subtle harms unaddressed. Alternatively, if revisions remain complex, smaller firms and nonprofits may face disproportionate compliance burdens relative to large corporates with specialized teams.
Outlook: The core contours of the HSR regime stabilize, though practical details continue evolving. Larger market participants internalize the new expectations, while smaller actors need support to keep up. Overall merger risk assessment becomes more evidence-driven but also more resource-intensive.
Developments: By 2029, major corporations maintain standardized, transaction-ready datasets on market shares, competitors, and supply relationships, reducing marginal costs of detailed filings. Agencies leverage analytics and screening tools to triage which transactions merit deeper attention, improving alignment between burden and risk. Courts accumulate a body of case law on what constitutes an adequately substantiated merger justification, refining expectations further.
Risks: Greater reliance on sophisticated analytics may disadvantage parties without access to advanced tools, raising fairness concerns. If enforcement resources do not keep pace with richer data inflows, bottlenecks could slow reviews, especially in complex industries. Some firms might attempt to game standard metrics, undercutting the value of data-driven screening and requiring additional safeguards.
Outlook: Detailed, data-heavy merger analysis becomes normal for large and complex deals. While this increases upfront work, it can also reduce surprises later in the process. The balance of deterrence and deal-making becomes more sensitive to how well data quality is maintained.
Developments: Healthcare, pharmaceuticals, and technology mergers feel the refined HSR regime most strongly, as agencies apply lessons from contested hospital and digital-platform deals. Precedents from the current litigation feed into broader debates over how far competition authorities can go in demanding forward-looking information and theories of harm. Some sectors respond with more joint ventures, minority stakes, and contractual alliances designed to avoid formal control thresholds.
Risks: Structural consolidation could continue under the radar through incremental or non-reportable transactions, eroding competition despite nominally stronger rules. Complex ownership structures may outpace regulators' ability to track ultimate control, particularly in private equity. Public frustration with persistent high prices or reduced choice might be blamed on perceived regulatory failure, prompting abrupt policy shifts.
Outlook: In key sectors, merger scrutiny is tougher and more data-driven than a decade earlier, but workarounds and loopholes remain. The practical impact on prices and innovation varies by industry. Political narratives around consolidation increasingly influence legal and regulatory strategies.
Developments: US merger review evolves alongside European and other major jurisdictions, sometimes converging on analytical frameworks and sometimes diverging based on case law and politics. Multinational companies design deals with multi-jurisdictional risk in mind, standardizing global dossiers to meet the strictest common denominator. Information-sharing and cooperation agreements between agencies deepen, allowing them to evaluate cross-border impacts more coherently.
Risks: Divergent thresholds or disclosure requirements can increase transaction complexity, particularly for mid-sized firms expanding abroad. If the US is seen as materially laxer or stricter than peers, it may either attract risky deals or push activity offshore. Trade tensions or data-localization rules could complicate cross-border evidence gathering, limiting agencies' ability to understand global competitive dynamics.
Outlook: The US system is embedded in an interlocking web of global merger regimes. Companies invest heavily in compliance and strategic planning, treating antitrust as a core component of international expansion. Long-run welfare effects depend on how well agencies coordinate across borders.
Developments: By the mid-2040s, digital markets, health platforms, and infrastructure sectors may have evolved into configurations not well anticipated by earlier HSR rules. Agencies experiment with new metrics, such as data-control indices or ecosystem dependence, and may incorporate them into notification requirements. Courts and legislatures revisit the scope of premerger review in light of lessons from decades of platform consolidation and deconsolidation.
Risks: If legal doctrines lag behind market realities, harm from entrenched gatekeepers or vertical integration could accumulate before regulators respond. Alternatively, overcorrection may impose heavy burdens on benign transactions, chilling investment in beneficial combinations. Political polarization might cause oscillations between strict and lax periods, undermining predictability for long-horizon investments.
Outlook: Merger control remains central but must adapt continually to changing business models. The effectiveness of HSR-style regimes depends on how flexibly they integrate new insights about competition. Stakeholders who invest in forward-looking analysis are better positioned than those who rely on static rules.
Developments: By the 2070s, societies may reassess the relative weight of structural merger control, conduct remedies, and broader industrial policy in managing market power. Technological shifts, such as decentralized production or pervasive AI coordination, could alter how concentration translates into harm. Historical experience with HSR and its successors informs whether ex ante review, ex post enforcement, or alternative mechanisms deliver better outcomes.
Risks: Complacency after periods of economic stability might lead to deregulation cycles that allow new forms of abuse, repeating past mistakes. Conversely, deeply entrenched bureaucratic procedures could persist even if they no longer target the main sources of market power. If climate and demographic pressures dominate policy agendas, competition issues may receive less sustained attention, with long-term costs that are hard to reverse.
Outlook: Premerger notification and review, in some evolved form, likely remain part of the competition toolkit but are complemented or partially replaced by other mechanisms. The specific balance depends on how technology, politics, and global governance develop. Lessons from the current HSR dispute shape expectations about evidence, justification, and accountability for regulatory power.